Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $530.00 MXN
Change Today +3.80 / 0.72%
Volume 1.0K
As of 4:09 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for pfizer inc (PFE*)

Year over year, Pfizer Inc. has seen revenues fall from $51.6B USD to $49.6B USD. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from $22.0B USD to $9.1B USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Revenues61,035.054,657.051,584.049,605.0
TOTAL REVENUES61,035.054,657.051,584.049,605.0
Cost of Goods Sold11,700.09,493.09,250.09,033.0
GROSS PROFIT49,335.045,164.042,334.040,572.0
Selling General & Admin Expenses, Total17,484.015,018.014,164.013,720.0
R&D Expenses8,004.06,705.06,551.07,150.0
Depreciation & Amortization, Total5,465.05,109.04,599.04,039.0
OTHER OPERATING EXPENSES, TOTAL30,953.026,832.025,314.024,909.0
OPERATING INCOME18,382.018,332.017,020.015,663.0
Interest Expense-1,681.0-1,522.0-1,414.0-1,360.0
Interest and Investment Income456.0382.0403.0425.0
NET INTEREST EXPENSE-1,225.0-1,140.0-1,011.0-935.0
Currency Exchange Gains (Loss)-264.0351.0132.0-314.0
Other Non-Operating Income (Expenses)472.0257.0293.01,902.0
EBT, EXCLUDING UNUSUAL ITEMS17,365.017,800.016,434.016,316.0
Merger & Restructuring Charges-4,415.0-2,775.0-1,704.0-949.0
Gain (Loss) on Sale of Investments253.0-332.0-111.0-214.0
Gain (Loss) on Sale of Assets--22.0697.0148.0
Other Unusual Items, Total-1,722.0-3,473.0400.0-3,063.0
Legal Settlements-784.0-2,220.01,307.0-993.0
Other Unusual Items-104.0-418.0-104.0-1,657.0
EBT, INCLUDING UNUSUAL ITEMS11,481.011,242.015,716.012,238.0
Income Tax Expense3,621.02,221.04,306.03,120.0
Minority Interest in Earnings-40.0-28.0-69.0-32.0
Earnings from Continuing Operations7,860.09,021.011,410.09,118.0
EARNINGS FROM DISCOUNTINUED OPERATIONS2,189.05,577.010,662.049.0
NET INCOME10,009.014,570.022,003.09,135.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS10,007.014,568.022,001.09,134.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS7,818.08,991.011,339.09,085.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE*:MM $530.00 MXN +3.80

PFE* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $112.85 USD +0.39
Merck & Co Inc $59.70 USD +0.24
Nestle SA SFr.73.75 CHF +0.10
Roche Holding AG SFr.282.50 CHF +1.80
Procter & Gamble Co/The $79.33 USD -0.06
View Industry Companies
 

Industry Analysis

PFE*

Industry Average

Valuation PFE* Industry Range
Price/Earnings 23.8x
Price/Sales 4.3x
Price/Book 3.1x
Price/Cash Flow 16.2x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.